Blue Fin Ltd. (Series 4)
The Artemis Catastrophe Bond and Insurance-linked Securities Deal Directory aims to provide a one-stop resource for information on every cat bond and ILS transaction we hold information on. The content of this Deal Directory is provided as is and there will be some omissions. Help us to keep these cat bond and ILS transaction summaries up to date by contacting us if you see an error or omission that you can correct.
Blue Fin Ltd. (Series 4) - At a glance:
- Issuer / SPV: Blue Fin Ltd. (Series 4)
- Cedent / Sponsor: Allianz
- Placement / structuring agent/s: Allianz Re structured the deal. Aon Benfield Securities and Swiss Re are joint bookrunners
- Risk modelling / calculation agents etc: AIR Worldwide
- Risks / Perils covered: U.S. hurricane, U.S. earthquake
- Size: $40m
- Trigger type: Modelled loss
- Ratings: NR
- Date of issue: Apr 2011
- Artemis.bm news coverage: Articles discussing Blue Fin Ltd. (Series 4) from Artemis.bm
Blue Fin Ltd. (Series 4) - Full details
The latest series of notes issued by Cayman Islands domiciled SPV Blue Fin Ltd.
This $40m of cat bond cover will provide Allianz with aggregate protection against U.S. hurricanes and earthquakes. The new series 4 Class B $40m of cover will run for the same period as the rest of last year’s Blue Fin Ltd. transaction, so it is expected that the maturity date will be during May 2013.
The deal priced at the upper end of expectations at 850bp above U.S. Treasury money market funds.
It’s safe to assume that the structure of the notes are identical to the Class B notes issued in 2010’s Blue Fin transaction. The Class A notes of that deal provided cover on a per-occurrence basis, while the Class B were aggregate cover. So with this additional $40m Allianz will have $100m of aggregate cat bond protection for U.S. hurricanes and earthquakes until May 2013.
The Artemis Catastrophe Bond & Insurance-Linked Securities Deal Directory is copyright © Steve Evans Ltd. Reproduction or publication without permission is not permitted. Use of this information within a commercial product, or for profit, without a license is strictly prohibited. Contact us if you would like to use this content or to discuss licensing.